Showing results (361-370 of 516) with videos related to

Sort By:
Pageof 52
Pathology, Research and Practice|March 6, 2020
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesisMatteo Fassan, Stefano Realdon, Luciano Cascione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy TrialElizabeth C Smyth, Matteo Fassan, David Cunningham, et al.
Frontiers in Endocrinology|March 14, 2022
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA ProfilingFrancesca Galuppini, Simona Censi, Isabella Merante Boschin, et al.
Translational Gastroenterology and Hepatology|August 28, 2018
Precision medicine in cholangiocarcinomaAntonio Pellino, Fotios Loupakis, Massimiliano Cadamuro, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal studyFlavia Bortolotti, Maria Guido, Samuela Bartolacci, et al.
Cancer Cell International|October 2, 2019
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastasesMatteo Fassan, Luca Vianello, Diana Sacchi, et al.
Oncotarget|September 13, 2014
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesisMatteo Fassan, Luigi Dall'Olmo, Marco Galasso, et al.
JHEP Reports : Innovation in Hepatology|May 27, 2021
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosisNora Cazzagon, Samantha Sarcognato, Annarosa Floreani, et al.
Endocrine Pathology|November 18, 2019
Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic MutationsValeria Maffeis, Rocco Cappellesso, Lorenzo Nicolè, et al.
Pageof 52